▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Cory Renauer

TMFang4apples

Cory Renauer is a contributing Motley Fool healthcare analyst covering pharmaceuticals, biotechnology, and medical devices. Previously, Cory was a laboratory technician for the American Red Cross. He holds a bachelor’s degree in biology from Oakland University.

Recent Articles by Cory Renauer

Getty - person in suit at desk laptop thoughtful thinking

Sep 28, 2025 by Cory Renauer

Why Pfizer's Post-COVID Future Looks Brighter Than Ever

A robust pipeline of experimental and recently launched drugs could make the next several years exciting ones to be a Pfizer shareholder.

a-person-delivering-a-presentation-getty

Sep 28, 2025 by Cory Renauer

The Biotech Stock That's Too Risky for Most Investors

It's unclear how long it's going to be before this company has a product to sell.

investor-doing-stuff-getty

Sep 23, 2025 by Cory Renauer

What's Pfizer Getting in Its $7.3 Billion Metsera Buyout?

Pfizer's plan to enter the booming obesity market took an expensive new turn.

investing-screen-analysis-investor-growth-stocks-getty

Sep 23, 2025 by Cory Renauer

1 Reason to Buy Bristol Myers Squibb Stock

Find out why investors seeking passive income want shares of this dividend payer in their portfolio.

individual-investors-at-home-getty

Sep 21, 2025 by Cory Renauer

These 2 Healthcare Stocks Are Up Over 100% in a Month. Can They Keep Climbing?

Here's what needs to happen for these high flyers to continue soaring.

cute-couple-investing-decisions-together

Sep 20, 2025 by Cory Renauer

The Healthcare REIT That Pays You to Wait for Demographics

Dividends from this stock ought to climb steadily as America gets older.

individual-investor-with-devices-getty

Sep 17, 2025 by Cory Renauer

2 High-Yield Dividend Stocks You'll Wish You Had Bought 10 Years From Now

These dividend payers cranked up their payouts over the past decade, and they could do it again.

investor-charts-closeup-getty

Sep 16, 2025 by Cory Renauer

1 Reason Intuitive Surgical (ISRG) Is 1 of the Best Healthcare Stocks You Can Buy Today

Find out how the company's da Vinci surgical robots could remain the preferred option for decades.

investor-smiling-while-sitting-at-a-table-and-typing-on-a-laptop-computer-getty

Sep 15, 2025 by Cory Renauer

1 Reason Wall Street Is Obsessed With Vertex Pharmaceuticals

Here's why you can't find a Wall Street analyst who will tell you to sell this stock.

investor-chart-stock-finance-wall-street-broker-getty

Sep 14, 2025 by Cory Renauer

Billionaire Phillipe Laffont Sold Coatue Management's Stake in Super Micro Computer and Snapped Up This Surgical Robotics Pioneer That's Up 19,390% Since Its IPO

An unbeatable advantage makes this stock a popular one among billionaire investors.

investor-looks-worried-at-computer-in-a-living-room-setting-getty

Sep 11, 2025 by Cory Renauer

2 Undervalued Healthcare Stocks to Buy in 2025 and Hold for Decades

A decade from now, you could regret ignoring these no-brainer stock picks.

coffee-shop-investor-getty

Sep 9, 2025 by Cory Renauer

Is Summit Therapeutics a Buy, Sell, or Hold Now?

Western results for ivonescimab aren't lining up with the huge survival benefit measured in China.

biotech-laboratory-getty

Sep 8, 2025 by Cory Renauer

1 Reason Every Investor Should Know About AbbVie (ABBV)

This company's past ability to extend patent-protected market exclusivity for its drugs bodes well for new investors.

investors-picking-stocks-on-computer-getty

Sep 7, 2025 by Cory Renauer

These 2 Healthcare Stocks More Than Doubled Recently and Could Soar Higher, According to Wall Street Analysts

Experts who follow these stocks think they can fly higher despite already gaining over 100% since the end of July.

smart-investor-drinking-coffee-and-buying-stocks

Sep 5, 2025 by Cory Renauer

2 S&P 500 Dividend Stocks That Could Climb More Than 20% According to Wall Street Analysts

Consensus price targets set by experts who follow these businesses are way above their recent prices.

gettyimages-man-smiles-on-phone-at-computer

Sep 5, 2025 by Cory Renauer

2 High-Yield Dividend ETFs You Can Buy With $200 in September and Hold Forever

You don't need to be rich to begin building a passive income stream that could fuel your retirement dreams.

investor-checking-stocks-at-computer

Sep 3, 2025 by Cory Renauer

Is Novo Nordisk Stock a Buy Now?

A 57% risk reduction for heart attacks and strokes sounds like an amazing result.

worried-businessman-working-in-office-with-his-coworker-and-having-problems

Sep 2, 2025 by Cory Renauer

These Were the S&P 500 Index's Worst Performing Stocks in August 2025

A few tech stocks that had previously led the S&P 500 index higher were under pressure last month.

individual-investor-three-stock-charts-getty

Sep 2, 2025 by Cory Renauer

3 High-Yield Dividend Stocks You Can Buy in September and Hold Forever

With an average yield above 6%, these stocks could do a lot to raise your passive income stream.

investing-young-couple-with-laptop

Aug 29, 2025 by Cory Renauer

2 Beaten-Down Stocks That Could Rocket 142% to 222% Higher, According to Wall Street Analysts

Investment bank analysts up and down Wall Street are pounding the table on these stocks.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services